AZN.L : Summary for ASTRAZENECA PLC ORD SHS $0.25 - Yahoo Finance

U.S. Markets closed

AstraZeneca PLC (AZN.L)


LSE - LSE Delayed Price. Currency in GBp
Add to watchlist
4,280.00+164.00 (+3.98%)
At close: 12:13 PM EST
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close4,116.00
Open4,149.50
Bid4,100.00 x 6100
Ask4,500.00 x 13000
Day's Range4,134.50 - 4,436.74
52 Week Range3,680.00 - 5,505.00
Volume5,521,097
Avg. Volume2,818,641
Market Cap54.14B
Beta0.46
PE Ratio (TTM)21.96
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield2.80 (5.51%)
Ex-Dividend DateN/A
1y Target EstN/A
  • How AstraZeneca plc (ADR) (AZN) Stacks Up Against Its Peers
    Insider Monkey16 hours ago

    How AstraZeneca plc (ADR) (AZN) Stacks Up Against Its Peers

    At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined that some of the stocks that they are collectively bullish on can help us generate returns above the broader indices. Out of thousands of stocks that hedge funds invest in, small-caps […]

  • Reutersyesterday

    AstraZeneca's immunotherapy enters U.S. approval process

    AstraZeneca's immunotherapy drug durvalumab, the British drugmaker's most important pipeline medicine, has been accepted for review by U.S. regulators against bladder cancer, potentially its first use. ...

  • Investopediayesterday

    AstraZeneca Cuts 700 Jobs, Citing Falling Revenues

    Falling revenues from its best-selling drugs have led to severe cost-cutting measures.